睿昂基因
(688217)
| 流通市值：13.83亿 | | | 总市值：13.83亿 |
| 流通股本：5585.59万 | | | 总股本：5585.59万 |
| 利润表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 营业总收入 | 79,836,487.02 | 35,864,096.63 | 177,260,777.73 | 139,103,619.1 |
| 营业总成本 | 84,388,710.24 | 40,535,955.17 | 196,970,472.1 | 153,715,390.64 |
| 其他经营收益 | | | | |
| 营业利润 | -9,991,075.84 | -7,989,435.67 | -49,375,570.34 | -15,996,127.68 |
| 利润总额 | -10,359,149.57 | -8,024,733.29 | -50,729,249.71 | -16,512,859.59 |
| 净利润 | -17,659,744.74 | -6,885,154.33 | -60,420,101.66 | -12,308,952.88 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | -4,622,209.64 | - |
| 综合收益总额 | -17,659,744.74 | -6,885,154.33 | -65,042,311.3 | -12,308,952.88 |
| 资产负债表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 流动资产: | | | | |
| 流动资产合计 | 429,162,472.7 | 420,883,556.16 | 427,794,647.28 | 440,132,705.37 |
| 非流动资产: | | | | |
| 非流动资产合计 | 432,805,476.18 | 449,131,417.75 | 457,599,445.58 | 507,694,217.7 |
| 资产总计 | 861,967,948.88 | 870,014,973.91 | 885,394,092.86 | 947,826,923.07 |
| 流动负债: | | | | |
| 流动负债合计 | 24,316,853 | 22,453,572.94 | 30,813,233.81 | 28,947,605.41 |
| 非流动负债: | | | | |
| 非流动负债合计 | 9,090,346.09 | 8,226,060.77 | 8,360,364.52 | 10,543,797.96 |
| 负债合计 | 33,407,199.09 | 30,679,633.71 | 39,173,598.33 | 39,491,403.37 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 832,534,263.08 | 839,891,946.76 | 844,875,139.66 | 903,635,431.6 |
| 股东权益合计 | 828,560,749.79 | 839,335,340.2 | 846,220,494.53 | 908,335,519.7 |
| 负债和股东权益合计 | 861,967,948.88 | 870,014,973.91 | 885,394,092.86 | 947,826,923.07 |
| 现金流量表 |
| 报告期 | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 92,832,866.32 | 44,870,003.08 | 216,238,957.37 | 167,217,286.23 |
| 经营活动现金流出小计 | 80,127,514.66 | 43,149,506.15 | 170,692,152.73 | 140,356,054.3 |
| 经营活动产生的现金流量净额 | 12,705,351.67 | 1,720,496.93 | 45,546,804.64 | 26,861,231.93 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 358,833,433.86 | 109,284,573.74 | 211,021,890.31 | 154,094,855.46 |
| 投资活动现金流出小计 | 335,514,306.55 | 91,137,846.18 | 257,761,268.9 | 184,258,952.91 |
| 投资活动产生的现金流量净额 | 23,319,127.31 | 18,146,727.56 | -46,739,378.59 | -30,164,097.45 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 1,167,311.68 | 746,988.8 | 28,936,868.05 | 18,199,331.59 |
| 筹资活动产生的现金流量净额 | -1,167,311.68 | -746,988.8 | -28,936,868.05 | -18,199,331.59 |
| 汇率变动对现金及现金等价物的影响 | -1,606,475.28 | -805,298.35 | -1,010,275.62 | -459,761.34 |
| 现金及现金等价物净增加额 | 33,250,692.02 | 18,314,937.34 | -31,139,717.62 | -21,961,958.45 |
| 期末现金及现金等价物余额 | 137,653,960.39 | 122,718,205.71 | 104,403,268.37 | 113,581,027.54 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | 33,250,692.02 | - | -31,139,717.62 | - |